S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
The Real Problem With "Made in America" Lithium (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
The Real Problem With "Made in America" Lithium (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
The Real Problem With "Made in America" Lithium (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores
S&P 500   4,221.02
DOW   33,061.57
QQQ   352.01
20 Best Healthcare Dividend Stocks to Invest in
Is Graphite the New Lithium? (Ad)
Nordstrom's Earnings Beat, A Rally In The Making
Money stored in Venmo and other payment apps could be vulnerable, financial watchdog warns
Is Graphite the New Lithium? (Ad)
What is the Penalty for Excess Contributions to an IRA?
Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come
The Real Problem With "Made in America" Lithium (Ad)
Okta, Inc: When Great Results Aren’t Good Enough 
How to Invest in Specialty Retail Stores
NASDAQ:NRC

National Research (NRC) Stock Forecast, Price & News

$43.92
-0.98 (-2.18%)
(As of 06/1/2023 ET)
Compare
Today's Range
$43.70
$45.00
50-Day Range
$40.78
$45.45
52-Week Range
$33.10
$47.60
Volume
31,300 shs
Average Volume
29,584 shs
Market Capitalization
$1.08 billion
P/E Ratio
36.30
Dividend Yield
1.09%
Price Target
N/A

National Research MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.07% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.25mentions of National Research in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$2.85 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Business Services Sector

273rd out of 684 stocks

Commercial Physical Research Industry

17th out of 32 stocks


NRC stock logo

About National Research (NASDAQ:NRC) Stock

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.

Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

NRC Stock News Headlines

Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
PSB Speakers: a brief history
The Real Problem With "Made in America" Lithium
Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.
National Research (NRC) Scheduled to Post Earnings on Tuesday
See More Headlines

NRC Price History

NRC Company Calendar

Last Earnings
2/11/2020
Ex-Dividend for 4/14 Dividend
3/30/2023
Dividend Payable
4/14/2023
Today
6/01/2023
Ex-Dividend for 7/14 Dividend
6/29/2023
Dividend Payable
7/14/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:NRC
Employees
511
Year Founded
1981

Profitability

Net Income
$31.80 million
Pretax Margin
27.00%

Debt

Sales & Book Value

Annual Sales
$151.57 million
Cash Flow
$1.51 per share
Book Value
$3.03 per share

Miscellaneous

Free Float
24,118,000
Market Cap
$1.08 billion
Optionable
Not Optionable
Beta
0.51

Social Links


Key Executives

  • Michael D. Hays
    President, Chief Executive Officer & Director
  • Jona S. Raasch
    Chief Operating Officer
  • Kevin R. Karas
    CFO, Secretary, Treasurer & Senior Vice President
  • Helen L Hrdy
    Chief Growth Officer
  • Jon Boumstein
    Chief Delivery Officer













NRC Stock - Frequently Asked Questions

How have NRC shares performed in 2023?

National Research's stock was trading at $37.30 at the beginning of 2023. Since then, NRC stock has increased by 17.7% and is now trading at $43.92.
View the best growth stocks for 2023 here
.

When is National Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our NRC earnings forecast
.

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) posted its quarterly earnings results on Tuesday, February, 11th. The company reported $0.34 EPS for the quarter. The company had revenue of $32.62 million for the quarter. National Research had a trailing twelve-month return on equity of 42.71% and a net margin of 20.20%.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research declared a quarterly dividend on Thursday, May 25th. Shareholders of record on Friday, June 30th will be paid a dividend of $0.12 per share on Friday, July 14th. This represents a $0.48 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend is Thursday, June 29th.
Read our dividend analysis for NRC
.

Is National Research a good dividend stock?

National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.10%. The dividend payout ratio is 39.67%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).

What is National Research's stock symbol?

National Research trades on the NASDAQ under the ticker symbol "NRC."

Who are National Research's major shareholders?

National Research's stock is owned by a variety of retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (13.05%), BlackRock Inc. (4.12%), Conestoga Capital Advisors LLC (2.98%), Dimensional Fund Advisors LP (2.56%), QV Investors Inc. (1.83%) and Renaissance Technologies LLC (1.49%). Insiders that own company stock include Amandla Mk Trust, Joann M Martin, John N Nunnelly, Jona S Raasch, Kevin R Karas and Steven D Jackson.
View institutional ownership trends
.

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Research's stock price today?

One share of NRC stock can currently be purchased for approximately $43.92.

How much money does National Research make?

National Research (NASDAQ:NRC) has a market capitalization of $1.08 billion and generates $151.57 million in revenue each year. The company earns $31.80 million in net income (profit) each year or $1.21 on an earnings per share basis.

How many employees does National Research have?

The company employs 511 workers across the globe.

Does National Research have any subsidiaries?
The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.
Read More
How can I contact National Research?

National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The official website for the company is www.nrchealth.com. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061.

This page (NASDAQ:NRC) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -